drugset / Trial / NCT05690802
The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV
NaSingle-groupOpen-labelTreatment
Summary
To observe and evaluate the safety and effectiveness of Palonosetron hydrochloride capsule in preventing acute nausea and vomiting caused by moderate emetic chemotherapy; The characteristics of the applicable population, clinical medication and clinical benefits of Palonosetron Hydrochloride Capsules were analyzed.
Timeline
- Start
- 2022-05-16
- Primary completion
- 2027-05-30
- Completion
- 2029-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Palonosetron | Other / unclassified | 0.5 mg | Oral |
Indications
No indication recorded.